Migraine, interferon β1a and siponimod immunomodulator therapies
Migraine, interferon β1a and siponimod immunomodulator therapies
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Autoimmunity seems to play a great role in the pathogenesis of migraine headache pain. There is far more evidence that interferon can exacerbate migraines. We report a case where remission of severe comorbid migraine attacks happened with the start of interferon β1a (Merck, Netherlands) immunomodulation therapy. Therapy for multiple sclerosis was d...
Alternative Titles
Full title
Migraine, interferon β1a and siponimod immunomodulator therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3dd52525a8be4472a568e48a0ecdf87e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3dd52525a8be4472a568e48a0ecdf87e
Other Identifiers
ISSN
1471-2253
E-ISSN
1471-2253
DOI
10.1186/s12871-022-01639-z
